Prenatal corticosteroids modify glutamatergic and gabaergic synapse genomic fabric: Insights from a novel animal model of infantile spasms

Journal of Neuroendocrinology

Volumn 25, Issue 11, 2013, Pages 964-979

  Iacobas, D A ^a   Iacobas, S ^a   Chachua, T ^a   Goletiani, C ^a   Sidyelyeva, G ^a   Veliskova J ^a   Velisek L ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

ACTH; Cortisol corticosterone; GABA; Glucocorticoids; Neuroactive steroids; Steroids

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; CORTICOTROPIN; DEOXYCORTICOSTERONE; N METHYL DEXTRO ASPARTIC ACID; SODIUM CHLORIDE; AMINO ACID RECEPTOR AFFECTING AGENT; GABAERGIC RECEPTOR AFFECTING AGENT;

ANIMAL MODEL; ARCUATE NUCLEUS; AUTORADIOGRAPHY; CORTICOSTEROID THERAPY; DOWN REGULATION; GABAERGIC TRANSMISSION; GENE EXPRESSION; GENOMICS; GLUTAMATERGIC TRANSMISSION; HYPOTHALAMUS; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; INFANTILE SPASM; LEARNING; NERVOUS SYSTEM PARAMETERS; NONHUMAN; PERINATAL PERIOD; PRENATAL CARE; PRENATAL EXPOSURE; PRENATAL STRESS; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; SYNAPSE; TRANSCRIPTOMICS; ANIMAL; DISEASE MODEL; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; NEWBORN; PREGNANCY; RAT; SPASMS, INFANTILE;

ADRENAL CORTEX HORMONES; ADRENOCORTICOTROPIC HORMONE; ANIMALS; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGENTS; FEMALE; GABA AGENTS; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; SPASMS, INFANTILE; SYNAPSES;

EID: 84886663140     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12061     Document Type: Review

References (163)

1. Hallman M, Peltoniemi O, Kari MA. Enhancing functional maturity before preterm birth. Neonatology 2010; 97: 373-378.
2. Vidaeff AC, Blackwell SC. Potential risks and benefits of antenatal corticosteroid therapy prior to preterm birth in pregnancies complicated by severe fetal growth restriction. Obstet Gynecol Clin North Am. 2011; 38: 205-214, ix.
3. Bergman K, Sarkar P, O'Connor TG, Modi N, Glover V. Maternal stress during pregnancy predicts cognitive ability and fearfulness in infancy. J Am Acad Child Adolesc Psychiatry 2007; 46: 1454-1463.
4. Cottrell EC, Seckl JR. Prenatal stress, glucocorticoids and the programming of adult disease. Front Behav Neurosci 2009; 3: 19.
5. Harris A, Seckl J. Glucocorticoids, prenatal stress and the programming of disease. Horm Behav 2011; 59: 279-289.
6. Markham JA, Koenig JI. Prenatal stress: role in psychotic and depressive diseases. Psychopharmacology 2011; 214: 89-106.
7. Trautman PD, Meyer-Bahlburg HF, Postelnek J, New MI. Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology 1995; 20: 439-449.
8. Peltoniemi OM, Kari MA, Hallman M. Repeated antenatal corticosteroid treatment: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2011; 90: 719-727.
9. Davis EP, Townsend EL, Gunnar MR, Georgieff MK, Guiang SF, Ciffuentes RF, Lussky RC. Effects of prenatal betamethasone exposure on regulation of stress physiology in healthy premature infants. Psychoneuroendocrinology 2004; 29: 1028-1036.
10. Davis EP, Waffarn F, Sandman CA. Prenatal treatment with glucocorticoids sensitizes the hpa axis response to stress among full-term infants. Dev Psychobiol 2011; 53: 175-183.
11. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 1999; 180: 114-121.
12. French NP, Hagan R, Evans SF, Mullan A, Newnham JP. Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. Am J Obstet Gynecol 2004; 190: 588-595.
13. Seckl JR. Physiologic programming of the fetus. Clin Perinatol 1998; 25: 939-962.
14. Smith GN, Kingdom JC, Penning DH, Matthews SG. Antenatal corticosteroids: is more better? Lancet 2000; 355: 251-252.
15. Bale TL, Baram TZ, Brown AS, Goldstein JM, Insel TR, McCarthy MM, Nemeroff CB, Reyes TM, Simerly RB, Susser ES, Nestler EJ. Early life programming and neurodevelopmental disorders. Biol Psychiatry 2010; 68: 314-319.
16. Dunn GA, Morgan CP, Bale TL. Sex-specificity in transgenerational epigenetic programming. Horm Behav 2011; 59: 290-295.
17. Roberge S, Lacasse Y, Tapp S, Tremblay Y, Kari A, Liu J, Fekih M, Qublan HS, Amorim MM, Bujold E. Role of fetal sex in the outcome of antenatal glucocorticoid treatment to prevent respiratory distress syndrome: systematic review and meta-analysis. J Obstet Gynaecol Can 2011; 33: 216-226.
18. Yunis KA, Bitar FF, Hayek P, Mroueh SM, Mikati M. Transient hypertrophic cardiomyopathy in the newborn following multiple doses of antenatal corticosteroids. Am J Perinat 1999; 16: 17-21.
19. Banks BA, Cnaan A, Morgan MA, Parer JT, Merrill JD, Ballard PL, Ballard RA. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American thyrotropin-releasing hormone study group. Am J Obstet Gynecol 1999; 181: 709-717.
20. Stott DH. Follow-up study from birth of the effects of prenatal stresses. Dev Med Child Neurol 1973; 15: 770-787.
21. Pedder J. Psychoanalytic views of aggression: some theoretical problems. Br J Med Psychol 1992; 65: 95-106.
22. Crowther CA, Doyle LW, Haslam RR, Hiller JE, Harding JE, Robinson JS. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med 2007; 357: 1179-1189.
23. Kinney DK, Munir KM, Crowley DJ, Miller AM. Prenatal stress and risk for autism. Neurosci Biobehav Rev 2008; 32: 1519-1532.
24. Sloboda DM, Challis JR, Moss TJ, Newnham JP. Synthetic glucocorticoids: antenatal administration and long-term implications. Curr Pharm Des 2005; 11: 1459-1472.
25. Chachua T, Yum M-S, Velíšková J, Velíšek L. Validation of the rat model of cryptogenic infantile spasms. Epilepsia 2011; 52: 1666-1677.
26. Hirvikoski T, Nordenstrom A, Lindholm T, Lindblad F, Ritzen EM, Wedell A, Lajic S. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. J Clin Endocrinol Metab 2007; 92: 542-548.
27. Lajic S, Nordenstrom A, Hirvikoski T. Long-term outcome of prenatal treatment of congenital adrenal hyperplasia. Endocr Dev 2008; 13: 82-98.
28. Sullivan PF. The genetics of schizophrenia. PLoS Med 2005; 2: e212.
29. Welberg LAM, Seckl JR. Prenatal stress, glucocorticoids and the programming of the brain. J Neuroendocr 2001; 13: 113-128.
30. Kapoor A, Petropoulos S, Matthews SG. Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids. Brain Res Rev 2008; 57: 586-595.
31. Brunson KL, Avishai-Eliner S, Hatalski CG, Baram TZ. Neurobiology of the stress response early in life: evolution of a concept and the role of corticotropin releasing hormone. Mol Psychiatry 2001; 6: 647-656.
32. Velíšek L, Jehle K, Asche S, Velíšková J. Model of infantile spasms induced by N-methyl-D-aspartic acid in prenatally impaired brain. Ann Neurol 2007; 61: 109-119.
33. Yum MS, Chachua T, Velíšková J, Velíšek L. Prenatal stress promotes development of spasms in infant rats. Epilepsia 2012; 53: e46-e49.
34. Edwards HE, Dortok D, Tam J, Won D, Burnham WM. Prenatal stress alters seizure thresholds and the development of kindled seizures in infant and adult rats. Horm Behav 2002; 42: 437-447.
35. Makara GB, Haller J. Non-genomic effects of glucocorticoids in the neural system. Evidence, mechanisms and implications. Prog Neurobiol 2001; 65: 367-390.
36. Iacobas DA, Iacobas S, Urban-Maldonado M, Spray DC. Sensitivity of the brain transcriptome to connexin ablation. Biochim Biophys Acta 2005; 1711: 183-196.
37. Iacobas DA, Iacobas S, Spray DC. Connexin43 and the brain transcriptome of newborn mice. Genomics 2007; 89: 113-123.
38. Iacobas DA, Iacobas S, Li WE, Zoidl G, Dermietzel R, Spray DC. Genes controlling multiple functional pathways are transcriptionally regulated in connexin43 null mouse heart. Physiol Genomics 2005; 20: 211-223.
39. Iacobas DA, Iacobas S, Urban-Maldonado M, Scemes E, Spray DC. Similar transcriptomic alterations in Cx43 knockdown and knockout astrocytes. Cell Commun Adhes 2008; 15: 195-206.
40. Iacobas DA, Iacobas S, Spray DC. Connexin-dependent transcellular transcriptomic networks in mouse brain. Prog Biophys Mol Biol 2007; 94: 169-185.
41. Iacobas S, Thomas NM, Iacobas DA. Plasticity of the myelination genomic fabric. Mol Gen Genom 2012; 287: 237-246.
42. 2+ wave spread in glia. Biophys J 2006; 90: 24-41.
43. Iacobas S, Iacobas DA. Astrocyte proximity modulates the myelination gene fabric of oligodendrocytes. Neuron Glia Biol 2011; 6: 157-169.
44. Spray DC, Iacobas DA. Organizational principles of the connexin-related brain transcriptome. J Membr Biol 2007; 218: 39-47.
45. Reul JM, van den Bosch FR, de Kloet ER. Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: functional implications. J Endocrinol 1987; 115: 459-467.
46. Reul JM, van den Bosch FR, de Kloet ER. Differential response of type I and type II corticosteroid receptors to changes in plasma steroid level and circadian rhythmicity. Neuroendocrinology 1987; 45: 407-412.
47. van Steensel B, Brink M, van der Meulen K, van Binnendijk EP, Wansink DG, de Jong L, de Kloet ER, van Driel R. Localization of the glucocorticoid receptor in discrete clusters in the cell nucleus. J Cell Sci 1995; 108: 3003-3011.
48. van Steensel B, Jenster G, Damm K, Brinkmann AO, van Driel R. Domains of the human androgen receptor and glucocorticoid receptor involved in binding to the nuclear matrix. J Cell Biochem 1995; 57: 465-478.
49. Helm KA, Han JS, Gallagher M. Effects of cholinergic lesions produced by infusions of 192 IgG-saporin on glucocorticoid receptor mrna expression in hippocampus and medial prefrontal cortex of the rat. Neuroscience 2002; 115: 765-774.
50. de Kloet ER. Hormones, brain and stress. Endocr Regul 2003; 37: 51-68.
51. Reul JM, de Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985; 117: 2505-2511.
52. Munck A, Mendel DB, Smith LI, Orti E. Glucocorticoid receptors and actions. Am Rev Respir Dis 1990; 141: S2-S10.
53. Beato M, Sanchez-Pacheco A. Interaction of steroid hormone receptors with the transcription initiation complex. Endocr Rev 1996; 17: 587-609.
54. De Kloet ER. Hormones and the stressed brain. Ann NY Acad Sci 2004; 1018: 1-15.
55. Muller M, Holsboer F, Keck ME. Genetic modification of corticosteroid receptor signalling: Novel insights into pathophysiology and treatment strategies of human affective disorders. Neuropeptides 2002; 36: 117-131.
56. McEwan IJ, Wright AP, Gustafsson JA. Mechanism of gene expression by the glucocorticoid receptor: Role of protein-protein interactions. BioEssays 1997; 19: 153-160.
57. Ing NH. Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger rnas. Biol Reprod 2005; 72: 1290-1296.
58. Jakoi ER, Panchision DM, Gerwin CM, DeLorenzo RJ. Post-transcriptional regulation of gene expression in hippocampal neurons by glutamate receptor activation. Brain Res 1995; 693: 124-132.
59. Galliher-Beckley AJ, Williams JG, Cidlowski JA. Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling. Mol Cell Biol 2011; 31: 4663-4675.
60. Dulac O. Infantile Spasms and West Syndrome. London: WB Saunders, 1994.
61. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Moshe SL, Nordli D, Plouin P, Scheffer IE. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE commission on classification and terminology, 2005-2009. Epilepsia. 2010; 51: 676-685.
62. Mackay MT, Weiss SK, Adams-Webber T, Ashwal S, Stephens D, Ballaban-Gill K, Baram TZ, Duchowny M, Hirtz D, Pellock JM, Shields WD, Shinnar S, Wyllie E, Snead OC 3rd. Practice parameter: Medical treatment of infantile spasms: report of the american academy of neurology and the child neurology society. Neurology 2004; 62: 1668-1681.
63. Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP. The United Kingdom infantile spasms study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 2004; 364: 1773-1778.
64. Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP. The United Kingdom infantile spasms study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 2005; 4: 712-717.
65. Hrachovy RA, Frost JD Jr. Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms/west syndrome). J Clin Neurophysiol 2003; 20: 408-425.
66. Webb DW, Fryer AE, Osborne JP. Morbidity associated with tuberous sclerosis: a population study. Dev Med Child Neurol 1996; 38: 146-155.
67. Riikonen R. A long-term follow-up study of 214 children with the syndrome of infantile spasms. Neuropediatrics 1982; 13: 14-23.
68. Partikian A, Mitchell WG. Neurodevelopmental and epilepsy outcomes in a North American cohort of patients with infantile spasms. J Child Neurol. 2010; 25: 423-428.
69. Cohen-Sadan S, Kramer U, Ben-Zeev B, Lahat E, Sahar E, Nevo Y, Eidlitz T, Zeharia A, Kivity S, Goldberg-Stern H. Multicenter long-term follow-up of children with idiopathic West syndrome: ACTH versus vigabatrin. Eur J Neurol 2009; 16: 482-487.
70. Gettig J, Cummings JP, Matuszewski KHP. ACTHar gel and cosyntropin review: clinical and financial implications. P&T. 2009; 34: 250-257.
71. Riikonen R, Donner M. Incidence and aetiology of infantile spasms from 1960 to 1976: a population study in Finland. Dev Med Child Neurol 1979; 21: 333-343.
72. Partikian A, Mitchell WG. Major adverse events associated with treatment of infantile spasms. J Child Neurol 2007; 22: 1360-1366.
73. Riikonen R. Long-term outcome of patients with West syndrome. Brain Dev 2001; 23: 683-687.
74. Riikonen R. Acth therapy of west syndrome: Finnish views. Brain Dev 2001; 23: 642-646.
75. Riikonen R. Epidemiological data of West syndrome in Finland. Brain Dev 2001; 23: 539-541.
76. Riikonen R. The latest on infantile spasms. Curr Opin Neurol 2005; 18: 91-95.
77. Dulac O, Soufflet C, Chiron C, Kaminska A. What is West syndrome? Int Rev Neurobiol 2002; 49: 1-22.
78. Hrachovy RA, Frost JD Jr. Infantile spasms. Pediatr Clin North Am 1989; 36: 311-329.
79. Hrachovy RA, Frost JD Jr. Infantile spasms: A disorder of the developing nervous system. In: Kellaway P, Noebels JL, eds. Problems and Concepts in Developmental Neurophysiology. Baltimore, MD: Johns Hopkins Press, 1989; 131-147.
80. Jeavons PM, Bower BD, Dimitrakoudi M. Long-term prognosis of 150 cases of 'West syndrome'. Epilepsia 1973; 14: 153-164.
81. Jeavons PM, Bower BD. The natural history of infantile spasms. Arch Dis Child 1961; 36: 17-22.
82. Rantala H, Putkonen T. Occurrence, outcome, and prognostic factors of infantile spasms and Lennox-Gastaut syndrome. Epilepsia 1999; 40: 286-289.
83. Caplan R, Siddarth P, Mathern G, Vinters H, Curtiss S, Levitt J, Asarnow R, Shields WD. Developmental outcome with and without successful intervention. Int Rev Neurobiol 2002; 49: 269-284.
84. Hamano S, Yoshinari S, Higurashi N, Tanaka M, Minamitani M, Eto Y. Developmental outcomes of cryptogenic West syndrome. J Pediatr 2007; 150: 295-299.
85. Hamano S, Yoshinari S, Higurashi N, Tanaka M, Minamitani M, Eto Y. Regional cerebral blood flow and developmental outcome in cryptogenic West syndrome. Epilepsia 2007; 48: 114-119.
86. Deonna T, Roulet E. Autistic spectrum disorder: evaluating a possible contributing or causal role of epilepsy. Epilepsia 2006; 47(Suppl. 2): 79-82.
87. Paciorkowski AR, Thio LL, Dobyns WB. Genetic and biologic classification of infantile spasms. Pediatr Neurol 2011; 45: 355-367.
88. Riikonen R. Infantile spasms: modern practical aspects. Acta Paediatr Scand 1984; 73: 1-12.
89. Saemundsen E, Ludvigsson P, Rafnsson V. Autism spectrum disorders in children with a history of infantile spasms: a population-based study. J Child Neurol 2007; 22: 1102-1107.
90. Saemundsen E, Ludvigsson P, Hilmarsdottir I, Rafnsson V. Autism spectrum disorders in children with seizures in the first year of life - a population-based study. Epilepsia 2007; 48: 1724-1730.
91. Stafstrom CE, Holmes GL. Infantile spasms: criteria for an animal model. Int Rev Neurobiol 2002; 49: 391-411.
92. Juhasz C, Chugani HT, Muzik O, Chugani DC. Hypotheses from functional neuroimaging studies. Int Rev Neurobiol 2002; 49: 37-55.
93. Chronwall BM. Anatomy and physiology of the neuroendocrine arcuate nucleus. Peptides 1985; 6(Suppl. 2): 1-11.
94. Langlais PJ, Wardlow ML, Yamamoto H. Changes in CSF neurotransmitters in infantile spasms. Pediatr Neurol 1991; 7: 440-445.
95. Lado FA, Moshe SL. Role of subcortical structures in the pathogenesis of infantile spasms: What are possible subcortical mediators? Int Rev Neurobiol 2002; 49: 115-140.
96. Brunson KL, Avishai-Eliner S, Baram TZ. ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability. Int Rev Neurobiol 2002; 49: 185-197.
97. Baram TZ. Pathophysiology of massive infantile spasms: perspective on the putative role of the brain adrenal axis. Ann Neurol 1993; 33: 231-236.
98. Baram TZ, Schultz L. Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Dev Brain Res 1991; 61: 97-101.
99. Baram TZ, Mitchell WG, Snead OC, Horton EJ, Saito M. Brain-adrenal axis hormones are altered in the CSF of infants with massive infantile spasms. Neurology 1992; 42: 1171-1175.
100. Avishai-Eliner S, Yi SJ, Baram TZ. Developmental profile of messenger RNA for the corticotropin-releasing hormone receptor in the rat limbic system. Brain Res Dev Brain Res 1996; 91: 159-163.
101. Baram TZ, Hatalski CG. Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci 1998; 21: 471-476.
102. Nalin A, Facchinetti F, Galli V, Petraglia F, Storchi R, Genazzani AR. Reduced ACTH content in cerebrospinal fluid of children affected by cryptogenic infantile spasms with hypsarrhythmia. Epilepsia 1985; 26: 446-449.
103. Heiskala H. CSF ACTH and beta-endorphin in infants with West syndrome and ACTH therapy. Brain Dev 1997; 19: 339-342.
104. Farwell J, Milstein J, Opheim K, Smith E, Glass S. Adrenocorticotropic hormone controls infantile spasms independently of cortisol stimulation. Epilepsia 1984; 25: 605-608.
105. Willig RP, Lagenstein I. Use of ACTH fragments of children with infantile spasms. Neuropediatrics 1982; 13: 55-58.
106. Holmes GL, Weber DA. Effects of ACTH on seizure susceptibility in the developing brain. Ann Neurol 1986; 20: 82-88.
107. Rogawski MA, Reddy DS. Neurosteroids and infantile spasms: the deoxycorticosterone hypothesis. Int Rev Neurobiol 2002; 49: 199-219.
108. Azzolina B, Ellsworth K, Andersson S, Geissler W, Bull HG, Harris GS. Inhibition of rat alpha-reductases by finasteride: Evidence for isozyme differences in the mechanism of inhibition. J Steroid Biochem Mol Biol 1997; 61: 55-64.
109. Baram TZ, Schultz L. ACTH does not control neonatal seizures induced by administration of exogenous corticotropin-releasing hormone. Epilepsia 1995; 36: 174-178.
110. Rho JM. Basic science behind the catastrophic epilepsies. Epilepsia 2004; 45(Suppl 5): 5-11.
111. Stafstrom CE. Infantile spasms: a critical review of emerging animal models. Epilepsy Curr 2009; 9: 75-81.
112. Stafstrom CE, Moshé SL, Swann JW, Nehlig A, Jacobs MP, Schwartzkroin PA. Models of pediatric epilepsies: Strategies and opportunities. Epilepsia 2006; 47: 1407-1414.
113. Mareš P, Velíšek L. N-methyl-d-aspartate (NMDA)-induced seizures in developing rats. Brain Res Dev Brain Res 1992; 65: 185-189.
114. Dulac O, Plouin P. Infantile spasms and West syndrome. In: Wyllie E, ed. The Treatment of Epilepsy: Principles and Practices. Philadelphia, PA: Lea and Febiger, 1993; 464-491.
115. Gottlieb A, Keydar I, Epstein HT. Rodent brain growth stages: an analytical review. Biol Neonate 1977; 32: 166-176.
116. Avishai-Eliner S, Brunson KL, Sandman CA, Baram TZ. Stressed-out, or in (utero)? Trends Neurosci 2002; 25: 518-524.
117. Kábová R, Liptáková S, Šlamberová R, Pometlová M, Velíšek L. Age-specific N-methyl-D-aspartate-induced seizures: perspectives for the west syndrome model. Epilepsia 1999; 40: 1357-1369.
118. 6 treatment in infantile spasms. Neuropediatrics 1986; 17: 7-10.
119. Mackay M, Weiss S, Snead OC 3rd. Treatment of infantile spasms: an evidence-based approach. Int Rev Neurobiol 2002; 49: 157-184.
120. Zupanc ML. Infantile spasms. Expert Opin Pharmacother 2003; 4: 2039-2048.
121. Stafstrom CE, Sasaki-Adams DM. NMDA-induced seizures in developing rats cause long-term learning impairment and increased seizure susceptibility. Epilepsy Res 2003; 53: 129-137.
122. Riikonen RS, Jaaskelainen J, Turpeinen U. Insulin-like growth factor-1 is associated with cognitive outcome in infantile spasms. Epilepsia 2010; 51: 1283-1289.
123. Nagamitsu S, Matsuishi T, Yamashita Y, Shimizu T, Iwanaga R, Murakami Y, Miyazaki M, Hashimoto T, Kato H. Decreased cerebrospinal fluid levels of beta-endorphin and ACTH in children with infantile spasms. J Neural Transm 2001; 108: 363-371.
124. Riikonen RS. How do cryptogenic and symptomatic infantile spasms differ? Review of biochemical studies in finnish patients. J Child Neurol 1996; 11: 383-388.
125. Yukizane S, Kimura Y, Yamashita Y, Matsuishi T, Horikawa H, Ando H, Yamashita F. Growth hormone deficiency of hypothalamic origin in septo-optic dysplasia. Eur J Pediatr 1990; 150: 30-33.
126. Owen D, Matthews SG. Glucocorticoids and sex-dependent development of brain glucocorticoid and mineralocorticoid receptors. Endocrinology 2003; 144: 2775-2784.
127. Baram TZ. Models for infantile spasms: an arduous journey to the holy grail. Ann Neurol 2007; 61: 89-91.
128. Stafstrom CE. Animal models of infantile spasms: Is the holy grail finally in sight? Epilepsy Curr 2008; 8: 131-133.
129. Baram TZ. Go 'West', Young man ... The quest for animal models of infantile spasms (West syndrome). Epilepsy Curr 2007; 7: 165-167.
130. Welberg LAM, Seckl JR, Holmes MC. Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour. Neuroscience 2001; 104: 71-79.
131. Harvey AS, Freeman JL. Epilepsy in hypothalamic hamartoma: clinical and EEG features. Semin Pediatr Neurol 2007; 14: 60-64.
132. Fohlen M, Lellouch A, Delalande O. Hypothalamic hamartoma with refractory epilepsy: surgical procedures and results in 18 patients. Epileptic Disord 2003; 5: 267-273.
133. Garcia-Segura LM, Rodriguez JR, Torres-Aleman I. Localization of the insulin-like growth factor i receptor in the cerebellum and hypothalamus of adult rats: an electron microscopic study. J Neurocytol 1997; 26: 479-490.
134. Kerrigan JF, Ng YT, Prenger E, Krishnamoorthy KS, Wang NC, Rekate HL. Hypothalamic hamartoma and infantile spasms. Epilepsia 2007; 48: 89-95.
135. Tellez-Zenteno JF, Serrano-Almeida C, Moien-Afshari F. Gelastic seizures associated with hypothalamic hamartomas. An update in the clinical presentation, diagnosis and treatment. Neuropsychiatr Dis Treat 2008; 4: 1021-1031.
136. Wakamoto H, Sumi A, Motoki T, Ohmori H. Positron emission tomography with glucose hypermetabolism of a hypothalamic hamartoma in infantile spasms associated with pallister-hall syndrome. Brain Dev 2010; 32: 677-680.
137. Shang NX, Zou LP, Zhao JB, Zhang F, Li H. Association between prenatal stress and infantile spasms: a case-control study in china. Pediatr Neurol 2010; 42: 181-186.
138. Hong AM, Turner Z, Hamdy RF, Kossoff EH. Infantile spasms treated with the ketogenic diet: Prospective single-center experience in 104 consecutive infants. Epilepsia 2010; 51: 1403-1407.
139. Numis AL, Yellen MB, Chu-Shore CJ, Pfeifer HH, Thiele EA. The relationship of ketosis and growth to the efficacy of the ketogenic diet in infantile spasms. Epilepsy Res 2011; 96: 172-175.
140. Freeman JM, Vining EP. Seizures decrease rapidly after fasting: preliminary studies of the ketogenic diet. Arch Pediatr Adolesc Med 1999; 153: 946-949.
141. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404: 661-671.
142. Vong L, Ye C, Yang Z, Choi B, Chua S Jr, Lowell BB. Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to pomc neurons. Neuron 2011; 71: 142-154.
143. Williams KW, Scott MM, Elmquist JK. Modulation of the central melanocortin system by leptin, insulin, and serotonin: co-ordinated actions in a dispersed neuronal network. Eur J Pharmacol 2011; 660: 2-12.
144. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M. The [14c] deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedures and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977; 28: 897-916.
145. Wree A. Principles of the 2-deoxyglucose method for the determination of the local cerebral glucose utilization. Eur J Morphol 1990; 28: 132-138.
146. Dragunow M, Robertson HA. Generalized seizures induce c-fos protein(s) in mammalian neurons. Neurosci Lett 1987; 82: 157-161.
147. Herrera DG, Robertson HA. Activation of c-fos in the brain. Prog Neurobiol 1996; 50: 83-107.
148. Seckl JR, Cleasby M, Nyirenda MJ. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming. Kidney Int 2000; 57: 1412-1417.
149. Weinstock M. The long-term behavioural consequences of prenatal stress. Neurosci Biobehav Rev 2008; 32: 1073-1086.
150. Son GH, Geum D, Chung S, Kim EJ, Jo JH, Kim CM, Lee KH, Kim H, Choi S, Kim HT, Lee CJ, Kim K. Maternal stress produces learning deficits associated with impairment of NMDA receptor-mediated synaptic plasticity. J Neurosci 2006; 26: 3309-3318.
151. Yaka R, Salomon S, Matzner H, Weinstock M. Effect of varied gestational stress on acquisition of spatial memory, hippocampal ltp and synaptic proteins in juvenile male rats. Behav Brain Res 2007; 179: 126-132.
152. Weinstock M, Matlina E, Maor GI, Rosen H, McEwen BS. Prenatal stress selectively alters the reactivity of the hypothalamic- pituitary adrenal system in the female rat. Brain Res 1992; 595: 195-200.
153. Aghajafari F, Murphy K, Matthews S, Ohlsson A, Amankwah K, Hannah M. Repeated doses of antenatal corticosteroids in animals: a systematic review. Am J Obstet Gynecol 2002; 186: 843-849.
154. Iacobas S, Neal-Perry G, Iacobas DA. Analyzing the cytoskeletal transcriptome: Sex differences in rat hypothalamus. In: Dermietzel R, ed. The Cytoskeleton: Imaging, Isolation, and Interaction. New York, NY: Springer, 2013; 119-133.
155. Lee CL, Frost JD Jr, Swann JW, Hrachovy RA. A new animal model of infantile spasms with unprovoked persistent seizures. Epilepsia 2008; 49: 298-307.
156. Scantlebury MH, Galanopoulou AS, Chudomelova L, Raffo E, Betancourth D, Moshe SL. A model of symptomatic infantile spasms syndrome. Neurobiol Dis 2010; 37: 604-612.
157. Cortez MA, Shen L, Wu Y, Aleem IS, Trepanier CH, Sadeghnia HR, Ashraf A, Kanawaty A, Liu CC, Stewart L, Snead OC. Infantile spasms and down syndrome: a new animal model. Pediatr Res 2009; 65: 499-503.
158. Price MG, Yoo JW, Burgess DL, Deng F, Hrachovy RA, Frost JD Jr, Noebels JL. A triplet repeat expansion genetic mouse model of infantile spasms syndrome, arx(gcg)10 + 7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment. J Neurosci 2009; 29: 8752-8763.
159. Marsh E, Fulp C, Gomez E, Nasrallah I, Minarcik J, Sudi J, Christian SL, Mancini G, Labosky P, Dobyns W, Brooks-Kayal A, Golden JA. Targeted loss of arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females. Brain 2009; 132: 1563-1576.
160. Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979; 3: 79-83.
161. Velíšek L, Moshé SL. Effects of brief seizures during development. In: Sutula T, Pitkanen A, eds. Do Seizures Damage the Brain. Amsterdam: Elsevier, 2002: 355-364.
162. Fukui M, Shimakawa S, Tanabe T, Nomura S, Kashiwagi M, Azumakawa K, Tamai H. Partial seizures during acth therapy in a cryptogenic west syndrome patient. Brain Dev 2013; Jan 23. pii: S0387-7604(13)00003-X. doi: 10.1016/j.braindev.2013.01.001. [Epub ahead of print].
163. Iacobas DA, Fan C, Iacobas S, Haddad GG. Integrated transcriptomic response to cardiac chronic hypoxia: translation regulators and response to stress in cell survival. Funct Integr Genomics 2008; 8: 265-275.